-
Lipid-lowering therapy in people living with HIV (PLWH)
So Ree Kim Korea University, Republic of Korea 08:30~08:48 -
Lipid-lowering therapy in cancer patients and survivors
Hiroshi Akazawa Kanazawa Medical University, Japan 08:48~09:06 -
Lipid-lowering therapy in patients with CKD
Eun-sil Koh The Catholic University of Korea, Republic of Korea 09:06~09:24 -
Cardiovascular prevention in hemodialysis: is omega-3 back?
Sang Ho Jo Hallym University, Republic of Korea 09:24~09:42 - Panel Discussion 09:42~10:00
-
Evolution of vulnerable plaques: from natural history to preventive intervention
Jin Ho Lee Kyung Hee University, Republic of Korea 13:45~14:03 -
High-risk plaque features on CCTA: identification and clinical implications
Sang Yoon Lee Sungkyunkwan University, Republic of Korea 14:03~14:21 -
Intravascular imaging of vulnerable plaques: insights from IVUS and OCT
TBD (Name) TBD (Affiliation, Country) 14:21~14:39 -
Coronary physiology and plaque vulnerability: integrative relationship and prognostic implications
Seok Hun Yang Seoul National University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
-
Defining residual cardiovascular risk in the post-LDL era: unmet needs and mechanisms
Hyung Joon Joo Korea University, Republic of Korea 16:10~16:28 -
Targeting residual risk: Lp(a), triglyceride-rich lipoproteins, and inflammation
Sung Gyun Ahn Yonsei University, Republic of Korea 16:28~16:46 -
Residual cardiovascular risk beyond LDL-C: the central role of ApoB lipoproteins
John Chapman Sorbonne University, France 16:46~17:04 -
Beyond less is more: navigating residual thrombotic and inflammatory risk in AF and stable CAD
Satoshi Yasuda Tohoku University, Japan 17:04~17:22 - Panel Discussion 17:22~17:40
